EXOZ
eXoZymes, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.03
+3.38%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.7x
Market Cap
$65.25M
MomentumView details →
1D Return
+3.38%
YTD Return
−34.95%
RSI (14)
58.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.7x
Market Cap
$65.25M
RSI (14)
58.9
MomentumView details →
1D Return
+3.38%
YTD Return
−34.95%
SummaryUpdated Jun 1, 2026
eXoZymes, Inc. (NASDAQ:EXOZ) is a synthetic biochemical company founded in 2014 and headquartered in Monrovia, California. The company went public in November 2024, representing a relatively new entrant to the public markets in the biotechnology sector. eXoZymes focuses on developing platform technologies for producing various chemicals through biological processes, positioning itself at the intersection of biotechnology and industrial chemistry.
Similar companies
Latest newsMore news →
eXoZymes announced that its optimized NCT process achieved a 10-fold productivity increase, advancing beyond original commercial-scale economic targets.17d agoeXoZymes was selected by the U.S. Department of Energy for the Genesis Mission to collaborate with Lawrence Berkeley National Laboratory on AI-powered digital twins for cell-free biomanufacturing, with total funding of approximately $747,000 including $147,000 awarded to eXoZymes.43d agoeXoZymes Inc. closed an underwritten public offering of common stock and warrants, raising approximately $5.95 million in gross proceeds.79d ago